Notices. Notice
1,276 words·~6 min read·
/register/2007/09/26/07-4739A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 6210-01-S OFFICE OF GOVERNMENT ETHICS Revised Updated OGE Senior Executive Service Performance Review Board AGENCY: Office of Government Ethics (OGE). ACTION: Notice. SUMMARY: A revised notice is hereby given of the appointment of members of the updated OGE Senior Executive Service
(SES)Performance Review Board. DATES: *Effective Date:* September 26, 2007. FOR FURTHER INFORMATION CONTACT: Daniel D. Dunning, Deputy Director for Administration and Information Management, Office of Government Ethics, Suite 500, 1201 New York Avenue, NW., Washington, DC 20005-3917; Telephone: 202-482-9300; TDD: 202-208-9293; FAX: 202-482-9237. SUPPLEMENTARY INFORMATION: 5 U.S.C. 4314(c) requires each agency to establish, in accordance with regulations prescribed by the Office of Personnel Management at 5 CFR part 430, subpart C and § 430.310 thereof in particular, one or more Senior Executive Service performance review boards. As a small executive branch agency, OGE has just one board. In order to ensure an adequate level of staffing and to avoid a constant series of recusals, the designated members of OGE's SES Performance Review Board are being drawn, as in the past, in large measure from the ranks of other agencies. The board shall review and evaluate the initial appraisal of each OGE senior executive's performance by his or her supervisor, along with any recommendations in each instance to the appointing authority relative to the performance of the senior executive. This revised notice updates the membership of OGE's SES Performance Review Board as it was most recently published at 72 FR 53773-53774 (September 20, 2007), in order to reflect the appointment of one new member from another agency to replace a member from an agency who was not able to serve on OGE's board this year. Approved: September 21, 2007. Robert I. Cusick, Director, Office of Government Ethics. The following officials have been appointed as regular members of the SES Performance Review Board of the Office of Government Ethics: Marilyn L. Glynn [Chair], General Counsel, Office of Government Ethics Daniel D. Dunning [Alternate Chair], Deputy Director for Administration and Information Management, Office of Government Ethics Daniel L. Koffsky, Special Counsel, Office of Legal Counsel, Department of Justice David Maggi, Chief, Ethics Law and Programs Division, Office of the Assistant General Counsel for Administration, Department of Commerce; and Robert A. Shapiro, Associate Solicitor for Legal Counsel, Department of Labor [FR Doc. E7-18973 Filed 9-25-07; 8:45 am] BILLING CODE 6345-02-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Disease Control and Prevention
(CDC)Grants for Public Health Research Dissertation, Program Announcement
(PA)PAR07-231, Panel B In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention
(CDC)announces the aforementioned meeting. *Time and Date:* 8 a.m.-4 p.m., November 15, 2007 (Closed). *Place:* Crowne Plaza Buckhead, 3377 Peachtree Road, NE., Atlanta, GA 30326, telephone 404-264-1111. *Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. *Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of “CDC Grants for Public Health Research Dissertation,” PA PAR07-231, Panel B. *Contact Person for More Information:* Susan B. Stanton, D.D.S., Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D 72, Atlanta, GA 30333, Telephone 404-639-4640. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: September 20, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7-18945 Filed 9-25-07; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Disease Control and Prevention
(CDC)Grants for Public Health Research Dissertation, Program Announcement
(PA)PAR07-231, Panel C In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention
(CDC)announces the aforementioned meeting. *Time and Date:* 8:30 a.m.-4 p.m., November 16, 2007 (Closed). *Place:* Crowne Plaza Buckhead, 3377 Peachtree Road, NE., Atlanta, GA 30326, telephone 404-264-1111. *Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. *Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of “CDC Grants for Public Health Research Dissertation,” PAR07-231, Panel C. *Contact Person for More Information:* Sheree Marshall Williams, Ph.D., M.Sc., Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D 72, Atlanta, GA 30333, Telephone 404-639-4896. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: September 20, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7-18947 Filed 9-25-07; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the President's Cancer Panel. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.s.C., as amended, because the premature disclosure of information and the discussions would likely to significantly frustrate implementation of recommendations. *Name of Committee:* President's Cancer Panel. *Date:* October 22, 2007. *Open:* October 22, 2007, 8 a.m.-4 p.m. *Agenda:* Strategies for Maximizing the Nation's Investment in Cancer. *Place:* Hyatt Regency La Jolla, 3777 La Jolla Village Drive, San Diego, CA 92122. *Closed:* October 22, 2007, 4:30 p.m.-6:30 p.m. *Agenda:* The Panel will discuss potential recommendations from current series “Strategies for Maximizing the Nation's Investment in Cancer” and discuss potential topics for the 2008/2009 series. *Place:* Hyatt Regency La Jolla, 3777 La Jolla Village Drive, San Diego, CA 92122. *Contact Person:* Abby Sandler, Ph.D, Executive Secretary, National Cancer Institute, National Institutes of Health, Building 6116, Room 212, 6116 Executive Boulevard, Bethesda, MD 20892, 301/451/9399. Any interested person may file written comments with the committee by forwarding the comments to the Contact Person listed on this notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute's/Center's home page: *deainfo.nci.nih.gov/advisory/pcp/pcp.htm* , where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research, 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 18, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07-4739 Filed 9-25-07; 8:45am]
Connectionstraces to 1
Traces to 1 document
2 references not yet in our index
- 5 CFR 430
- Pub. L. 92-463
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources